BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Serhan CN. Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms. FASEB J. 2017;31:1273-1288. [PMID: 28087575 DOI: 10.1096/fj.201601222r] [Cited by in Crossref: 282] [Cited by in F6Publishing: 158] [Article Influence: 56.4] [Reference Citation Analysis]
Number Citing Articles
1 Chen G, Zhang YQ, Qadri YJ, Serhan CN, Ji RR. Microglia in Pain: Detrimental and Protective Roles in Pathogenesis and Resolution of Pain. Neuron 2018;100:1292-311. [PMID: 30571942 DOI: 10.1016/j.neuron.2018.11.009] [Cited by in Crossref: 172] [Cited by in F6Publishing: 168] [Article Influence: 57.3] [Reference Citation Analysis]
2 Kwon M, Lee J, Park S, Kwon OH, Seo J, Roh S. Exopolysaccharide Isolated from Lactobacillus plantarum L-14 Has Anti-Inflammatory Effects via the Toll-Like Receptor 4 Pathway in LPS-Induced RAW 264.7 Cells. Int J Mol Sci 2020;21:E9283. [PMID: 33291425 DOI: 10.3390/ijms21239283] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Regidor PA, Mueller A, Sailer M, Gonzalez Santos F, Rizo JM, Egea FM. Chronic Inflammation in PCOS: The Potential Benefits of Specialized Pro-Resolving Lipid Mediators (SPMs) in the Improvement of the Resolutive Response. Int J Mol Sci 2020;22:E384. [PMID: 33396555 DOI: 10.3390/ijms22010384] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
4 Wetzel A, Bonnefoy F, Chagué C, Vetter M, Couturier M, Baffert B, Adotévi O, Saas P, Perruche S. Pro-Resolving Factor Administration Limits Cancer Progression by Enhancing Immune Response Against Cancer Cells. Front Immunol 2022;12:812171. [DOI: 10.3389/fimmu.2021.812171] [Reference Citation Analysis]
5 Terkeltaub R. What makes gouty inflammation so variable? BMC Med 2017;15:158. [PMID: 28818081 DOI: 10.1186/s12916-017-0922-5] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 6.4] [Reference Citation Analysis]
6 Yin P, Wei Y, Wang X, Zhu M, Feng J. Roles of Specialized Pro-Resolving Lipid Mediators in Cerebral Ischemia Reperfusion Injury. Front Neurol 2018;9:617. [PMID: 30131754 DOI: 10.3389/fneur.2018.00617] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
7 Di Sessa A, Riccio S, Pirozzi E, Verde M, Passaro AP, Umano GR, Guarino S, Miraglia del Giudice E, Marzuillo P. Advances in paediatric nonalcoholic fatty liver disease: Role of lipidomics. World J Gastroenterol 2021; 27(25): 3815-3824 [PMID: 34321846 DOI: 10.3748/wjg.v27.i25.3815] [Reference Citation Analysis]
8 Mazzocchi A, De Cosmi V, Risé P, Milani GP, Turolo S, Syrén ML, Sala A, Agostoni C. Bioactive Compounds in Edible Oils and Their Role in Oxidative Stress and Inflammation. Front Physiol 2021;12:659551. [PMID: 33995124 DOI: 10.3389/fphys.2021.659551] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Hu X, Zhang YA, Chen B, Jin Z, Lin ML, Li M, Mei HX, Lu JC, Gong YQ, Jin SW, Zheng SX. Protectin DX promotes the inflammatory resolution via activating COX-2/L-PGDS-PGD2 and DP1 receptor in acute respiratory distress syndrome. Int Immunopharmacol 2022;102:108348. [PMID: 34920958 DOI: 10.1016/j.intimp.2021.108348] [Reference Citation Analysis]
10 Subramaniyan S, Terrando N. Neuroinflammation and Perioperative Neurocognitive Disorders. Anesth Analg 2019;128:781-8. [PMID: 30883423 DOI: 10.1213/ANE.0000000000004053] [Cited by in Crossref: 61] [Cited by in F6Publishing: 27] [Article Influence: 20.3] [Reference Citation Analysis]
11 Sønderskov J, Tungen JE, Palmas F, Dalli J, Serhan CN, Stenstrøm Y, Hansen TV. Stereoselective synthesis of MaR2n-3 DPA. Tetrahedron Lett 2020;61:151510. [PMID: 33273748 DOI: 10.1016/j.tetlet.2019.151510] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Surai PF, Kochish II, Kidd MT. Redox Homeostasis in Poultry: Regulatory Roles of NF-κB. Antioxidants (Basel) 2021;10:186. [PMID: 33525511 DOI: 10.3390/antiox10020186] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
13 Chiang N, Serhan CN. Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors. Mol Aspects Med 2017;58:114-29. [PMID: 28336292 DOI: 10.1016/j.mam.2017.03.005] [Cited by in Crossref: 138] [Cited by in F6Publishing: 134] [Article Influence: 27.6] [Reference Citation Analysis]
14 Maciejewska-Markiewicz D, Stachowska E, Hawryłkowicz V, Stachowska L, Prowans P. The Role of Resolvins, Protectins and Marensins in Non-Alcoholic Fatty Liver Disease (NAFLD). Biomolecules 2021;11:937. [PMID: 34202667 DOI: 10.3390/biom11070937] [Reference Citation Analysis]
15 Chiang N, Barnaeva E, Hu X, Marugan J, Southall N, Ferrer M, Serhan CN. Identification of Chemotype Agonists for Human Resolvin D1 Receptor DRV1 with Pro-Resolving Functions. Cell Chem Biol 2019;26:244-254.e4. [PMID: 30554914 DOI: 10.1016/j.chembiol.2018.10.023] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
16 Liu X, Davis CM, Alkayed NJ. P450 Eicosanoids and Reactive Oxygen Species Interplay in Brain Injury and Neuroprotection. Antioxid Redox Signal 2018;28:987-1007. [PMID: 28298143 DOI: 10.1089/ars.2017.7056] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
17 Bisicchia E, Sasso V, Catanzaro G, Leuti A, Besharat ZM, Chiacchiarini M, Molinari M, Ferretti E, Viscomi MT, Chiurchiù V. Resolvin D1 Halts Remote Neuroinflammation and Improves Functional Recovery after Focal Brain Damage Via ALX/FPR2 Receptor-Regulated MicroRNAs. Mol Neurobiol 2018;55:6894-905. [PMID: 29357041 DOI: 10.1007/s12035-018-0889-z] [Cited by in Crossref: 56] [Cited by in F6Publishing: 52] [Article Influence: 14.0] [Reference Citation Analysis]
18 Flak MB, Colas RA, Muñoz-Atienza E, Curtis MA, Dalli J, Pitzalis C. Inflammatory arthritis disrupts gut resolution mechanisms, promoting barrier breakdown by Porphyromonas gingivalis. JCI Insight 2019;4:125191. [PMID: 31292292 DOI: 10.1172/jci.insight.125191] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
19 Staurengo-Ferrari L, Badaro-Garcia S, Hohmann MSN, Manchope MF, Zaninelli TH, Casagrande R, Verri WA Jr. Contribution of Nrf2 Modulation to the Mechanism of Action of Analgesic and Anti-inflammatory Drugs in Pre-clinical and Clinical Stages. Front Pharmacol 2018;9:1536. [PMID: 30687097 DOI: 10.3389/fphar.2018.01536] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 12.0] [Reference Citation Analysis]
20 Libby P, Kobold S. Inflammation: a common contributor to cancer, aging, and cardiovascular diseases-expanding the concept of cardio-oncology. Cardiovasc Res 2019;115:824-9. [PMID: 30830168 DOI: 10.1093/cvr/cvz058] [Cited by in Crossref: 49] [Cited by in F6Publishing: 41] [Article Influence: 24.5] [Reference Citation Analysis]
21 Chistyakov DV, Azbukina NV, Lopachev AV, Kulichenkova KN, Astakhova AA, Sergeeva MG. Rosiglitazone as a Modulator of TLR4 and TLR3 Signaling Pathways in Rat Primary Neurons and Astrocytes. Int J Mol Sci 2018;19:E113. [PMID: 29301276 DOI: 10.3390/ijms19010113] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
22 Callan N, Hanes D, Bradley R. Early evidence of efficacy for orally administered SPM-enriched marine lipid fraction on quality of life and pain in a sample of adults with chronic pain. J Transl Med 2020;18:401. [PMID: 33087142 DOI: 10.1186/s12967-020-02569-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Hasselbach L, Weidner J, Elsässer A, Theilmeier G. Heart Failure Relapses in Response to Acute Stresses – Role of Immunological and Inflammatory Pathways. Front Cardiovasc Med 2022;9:809935. [DOI: 10.3389/fcvm.2022.809935] [Reference Citation Analysis]
24 Serhan CN, Chiang N, Dalli J. New pro-resolving n-3 mediators bridge resolution of infectious inflammation to tissue regeneration. Mol Aspects Med 2018;64:1-17. [PMID: 28802833 DOI: 10.1016/j.mam.2017.08.002] [Cited by in Crossref: 92] [Cited by in F6Publishing: 106] [Article Influence: 18.4] [Reference Citation Analysis]
25 Yang A, Wu Y, Yu G, Wang H. Role of specialized pro-resolving lipid mediators in pulmonary inflammation diseases: mechanisms and development. Respir Res 2021;22:204. [PMID: 34261470 DOI: 10.1186/s12931-021-01792-y] [Reference Citation Analysis]
26 Fedson DS. Influenza, evolution, and the next pandemic. Evol Med Public Health 2018;2018:260-9. [PMID: 30455951 DOI: 10.1093/emph/eoy027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
27 Perretti M, Di Filippo C, D'Amico M, Dalli J. Characterizing the anti-inflammatory and tissue protective actions of a novel Annexin A1 peptide. PLoS One 2017;12:e0175786. [PMID: 28407017 DOI: 10.1371/journal.pone.0175786] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
28 Bayani A, Dunster JL, Crofts JJ, Nelson MR. Mechanisms and Points of Control in the Spread of Inflammation: A Mathematical Investigation. Bull Math Biol 2020;82:45. [PMID: 32222839 DOI: 10.1007/s11538-020-00709-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
29 Zahoor I, Giri S. Specialized Pro-Resolving Lipid Mediators: Emerging Therapeutic Candidates for Multiple Sclerosis. Clin Rev Allergy Immunol 2021;60:147-63. [PMID: 32495237 DOI: 10.1007/s12016-020-08796-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
30 Kuffler DP. Mechanisms for Reducing Neuropathic Pain. Mol Neurobiol 2020;57:67-87. [PMID: 31813127 DOI: 10.1007/s12035-019-01757-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
31 Berger M, Terrando N, Smith SK, Browndyke JN, Newman MF, Mathew JP. Neurocognitive Function after Cardiac Surgery: From Phenotypes to Mechanisms. Anesthesiology 2018;129:829-51. [PMID: 29621031 DOI: 10.1097/ALN.0000000000002194] [Cited by in Crossref: 56] [Cited by in F6Publishing: 30] [Article Influence: 18.7] [Reference Citation Analysis]
32 Nesman JI, Chen O, Luo X, Ji RR, Serhan CN, Hansen TV. A new synthetic protectin D1 analog 3-oxa-PD1n-3 DPA reduces neuropathic pain and chronic itch in mice. Org Biomol Chem 2021;19:2744-52. [PMID: 33687402 DOI: 10.1039/d0ob02136a] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Saika A, Nagatake T, Kunisawa J. Host- and Microbe-Dependent Dietary Lipid Metabolism in the Control of Allergy, Inflammation, and Immunity. Front Nutr 2019;6:36. [PMID: 31024921 DOI: 10.3389/fnut.2019.00036] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
34 Onali S, Favale A, Fantini MC. The Resolution of Intestinal Inflammation: The Peace-Keeper's Perspective. Cells 2019;8:E344. [PMID: 30979024 DOI: 10.3390/cells8040344] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
35 Halade GV, Kain V, Serhan CN. Immune responsive resolvin D1 programs myocardial infarction-induced cardiorenal syndrome in heart failure. FASEB J 2018;32:3717-29. [PMID: 29455574 DOI: 10.1096/fj.201701173RR] [Cited by in Crossref: 38] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]
36 Antonsen SG, Gallantree-Smith H, Görbitz CH, Hansen TV, Stenstrøm YH, Nolsøe JMJ. Stereopermutation on the Putative Structure of the Marine Natural Product Mucosin. Molecules 2017;22:E1720. [PMID: 29027970 DOI: 10.3390/molecules22101720] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
37 Mezzetti M, Bionaz M, Trevisi E. Interaction between inflammation and metabolism in periparturient dairy cows. J Anim Sci 2020;98:S155-74. [PMID: 32810244 DOI: 10.1093/jas/skaa134] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
38 Fu T, Mohan M, Brennan EP, Woodman OL, Godson C, Kantharidis P, Ritchie RH, Qin CX. Therapeutic Potential of Lipoxin A4 in Chronic Inflammation: Focus on Cardiometabolic Disease. ACS Pharmacol Transl Sci 2020;3:43-55. [PMID: 32259087 DOI: 10.1021/acsptsci.9b00097] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
39 Fernandez RF, Kim SQ, Zhao Y, Foguth RM, Weera MM, Counihan JL, Nomura DK, Chester JA, Cannon JR, Ellis JM. Acyl-CoA synthetase 6 enriches the neuroprotective omega-3 fatty acid DHA in the brain. Proc Natl Acad Sci U S A 2018;115:12525-30. [PMID: 30401738 DOI: 10.1073/pnas.1807958115] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
40 Chen J, Purvis GSD, Collotta D, Al Zoubi S, Sugimoto MA, Cacace A, Martin L, Colas RA, Collino M, Dalli J, Thiemermann C. RvE1 Attenuates Polymicrobial Sepsis-Induced Cardiac Dysfunction and Enhances Bacterial Clearance. Front Immunol 2020;11:2080. [PMID: 32983159 DOI: 10.3389/fimmu.2020.02080] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
41 Hirata SI, Nagatake T, Sawane K, Hosomi K, Honda T, Ono S, Shibuya N, Saito E, Adachi J, Abe Y, Isoyama J, Suzuki H, Matsunaga A, Tomonaga T, Kiyono H, Kabashima K, Arita M, Kunisawa J. Maternal ω3 docosapentaenoic acid inhibits infant allergic dermatitis through TRAIL-expressing plasmacytoid dendritic cells in mice. Allergy 2020;75:1939-55. [PMID: 32027039 DOI: 10.1111/all.14217] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
42 Bennett JM, Reeves G, Billman GE, Sturmberg JP. Inflammation-Nature's Way to Efficiently Respond to All Types of Challenges: Implications for Understanding and Managing "the Epidemic" of Chronic Diseases. Front Med (Lausanne) 2018;5:316. [PMID: 30538987 DOI: 10.3389/fmed.2018.00316] [Cited by in Crossref: 65] [Cited by in F6Publishing: 48] [Article Influence: 16.3] [Reference Citation Analysis]
43 Zaninelli TH, Fattori V, Verri WA Jr. Harnessing Inflammation Resolution in Arthritis: Current Understanding of Specialized Pro-resolving Lipid Mediators' Contribution to Arthritis Physiopathology and Future Perspectives. Front Physiol 2021;12:729134. [PMID: 34539449 DOI: 10.3389/fphys.2021.729134] [Reference Citation Analysis]
44 Buechler C, Pohl R, Aslanidis C. Pro-Resolving Molecules-New Approaches to Treat Sepsis? Int J Mol Sci 2017;18:E476. [PMID: 28241480 DOI: 10.3390/ijms18030476] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
45 Zhang Z, Ma Q, Shah B, Mackensen GB, Lo DC, Mathew JP, Podgoreanu MV, Terrando N. Neuroprotective Effects of Annexin A1 Tripeptide after Deep Hypothermic Circulatory Arrest in Rats. Front Immunol 2017;8:1050. [PMID: 28912778 DOI: 10.3389/fimmu.2017.01050] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
46 Markworth JF, Brown LA, Lim E, Floyd C, Larouche J, Castor-Macias JA, Sugg KB, Sarver DC, Macpherson PC, Davis C, Aguilar CA, Maddipati KR, Brooks SV. Resolvin D1 supports skeletal myofiber regeneration via actions on myeloid and muscle stem cells. JCI Insight 2020;5:137713. [PMID: 32750044 DOI: 10.1172/jci.insight.137713] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
47 Parashar K, Schulte F, Hardt M, Baker OJ. Sex-mediated elevation of the specialized pro-resolving lipid mediator levels in a Sjögren's syndrome mouse model. FASEB J 2020;34:7733-44. [PMID: 32277856 DOI: 10.1096/fj.201902196R] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
48 Dos Santos HT, Nam K, Maslow F, Trump B, Baker OJ. Specialized pro-resolving receptors are expressed in salivary glands with Sjögren's syndrome. Ann Diagn Pathol 2021;56:151865. [PMID: 34847389 DOI: 10.1016/j.anndiagpath.2021.151865] [Reference Citation Analysis]
49 Wieczfinska J, Sitarek P, Kowalczyk T, Pawliczak R. Leonurus sibiricus root extracts decrease airway remodeling markers expression in fibroblasts. Clin Exp Immunol 2020;202:28-46. [PMID: 32562256 DOI: 10.1111/cei.13481] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
50 Matsuzaki S, Pouly JL, Canis M. Dose-dependent pro- or anti-fibrotic responses of endometriotic stromal cells to interleukin-1β and tumor necrosis factor α. Sci Rep 2020;10:9467. [PMID: 32528066 DOI: 10.1038/s41598-020-66298-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
51 Park J, Langmead CJ, Riddy DM. New Advances in Targeting the Resolution of Inflammation: Implications for Specialized Pro-Resolving Mediator GPCR Drug Discovery. ACS Pharmacol Transl Sci 2020;3:88-106. [PMID: 32259091 DOI: 10.1021/acsptsci.9b00075] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 11.5] [Reference Citation Analysis]
52 Hamilton JA, Hasturk H, Kantarci A, Serhan CN, Van Dyke T. Atherosclerosis, Periodontal Disease, and Treatment with Resolvins. Curr Atheroscler Rep 2017;19:57. [PMID: 29110146 DOI: 10.1007/s11883-017-0696-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 4.4] [Reference Citation Analysis]
53 De Gregori M, Belfer I, De Giorgio R, Marchesini M, Muscoli C, Rondanelli M, Martini D, Mena P, Arranz LI, Lorente-Cebrián S, Perna S, Villarini A, Salamone M, Allegri M, Schatman ME. Second edition of SIMPAR's "Feed Your Destiny" workshop: the role of lifestyle in improving pain management. J Pain Res 2018;11:1627-36. [PMID: 30214272 DOI: 10.2147/JPR.S160660] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
54 Serhan CN, Gupta SK, Perretti M, Godson C, Brennan E, Li Y, Soehnlein O, Shimizu T, Werz O, Chiurchiù V, Azzi A, Dubourdeau M, Gupta SS, Schopohl P, Hoch M, Gjorgevikj D, Khan FM, Brauer D, Tripathi A, Cesnulevicius K, Lescheid D, Schultz M, Särndahl E, Repsilber D, Kruse R, Sala A, Haeggström JZ, Levy BD, Filep JG, Wolkenhauer O. The Atlas of Inflammation Resolution (AIR). Mol Aspects Med 2020;74:100894. [PMID: 32893032 DOI: 10.1016/j.mam.2020.100894] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]
55 Zhu M, Wang X, Sun L, Schultzberg M, Hjorth E. Can inflammation be resolved in Alzheimer's disease? Ther Adv Neurol Disord 2018;11:1756286418791107. [PMID: 30116300 DOI: 10.1177/1756286418791107] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
56 Yin P, Wang X, Wang S, Wei Y, Feng J, Zhu M. Maresin 1 Improves Cognitive Decline and Ameliorates Inflammation in a Mouse Model of Alzheimer's Disease. Front Cell Neurosci 2019;13:466. [PMID: 31680874 DOI: 10.3389/fncel.2019.00466] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
57 Brennan EP, Mohan M, McClelland A, Tikellis C, Ziemann M, Kaspi A, Gray SP, Pickering R, Tan SM, Ali-Shah ST, Guiry PJ, El-Osta A, Jandeleit-Dahm K, Cooper ME, Godson C, Kantharidis P. Lipoxins Regulate the Early Growth Response-1 Network and Reverse Diabetic Kidney Disease. J Am Soc Nephrol 2018;29:1437-48. [PMID: 29490938 DOI: 10.1681/ASN.2017101112] [Cited by in Crossref: 24] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
58 Ammendola R, Parisi M, Esposito G, Cattaneo F. Pro-Resolving FPR2 Agonists Regulate NADPH Oxidase-Dependent Phosphorylation of HSP27, OSR1, and MARCKS and Activation of the Respective Upstream Kinases. Antioxidants (Basel) 2021;10:134. [PMID: 33477989 DOI: 10.3390/antiox10010134] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
59 Placha D, Jampilek J. Chronic Inflammatory Diseases, Anti-Inflammatory Agents and Their Delivery Nanosystems. Pharmaceutics 2021;13:64. [PMID: 33419176 DOI: 10.3390/pharmaceutics13010064] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
60 Zhang J, Wang M, Ye J, Liu J, Xu Y, Wang Z, Ye D, Zhao M, Wan J. The Anti-inflammatory Mediator Resolvin E1 Protects Mice Against Lipopolysaccharide-Induced Heart Injury. Front Pharmacol 2020;11:203. [PMID: 32256344 DOI: 10.3389/fphar.2020.00203] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
61 Regidor PA. Covid-19 management with inflammation resolving mediators? Perspectives and potential. Med Hypotheses 2020;142:109813. [PMID: 32416413 DOI: 10.1016/j.mehy.2020.109813] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
62 Rinschen MM, Ivanisevic J, Giera M, Siuzdak G. Identification of bioactive metabolites using activity metabolomics. Nat Rev Mol Cell Biol 2019;20:353-67. [PMID: 30814649 DOI: 10.1038/s41580-019-0108-4] [Cited by in Crossref: 143] [Cited by in F6Publishing: 131] [Article Influence: 71.5] [Reference Citation Analysis]
63 Zhang X, Matsuda M, Yaegashi N, Nabe T, Kitatani K. Regulation of Necroptosis by Phospholipids and Sphingolipids. Cells 2020;9:E627. [PMID: 32151027 DOI: 10.3390/cells9030627] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
64 Nienaber A, Hayford FEA, Variava E, Martinson N, Malan L. The Manipulation of the Lipid Mediator Metabolism as Adjunct Host-Directed Therapy in Tuberculosis. Front Immunol 2021;12:623941. [PMID: 33777003 DOI: 10.3389/fimmu.2021.623941] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 Tungen JE, Gerstmann L, Vik A, De Matteis R, Colas RA, Dalli J, Chiang N, Serhan CN, Kalesse M, Hansen TV. Resolving Inflammation: Synthesis, Configurational Assignment, and Biological Evaluations of RvD1n-3 DPA. Chemistry 2019;25:1476-80. [PMID: 30511787 DOI: 10.1002/chem.201806029] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
66 Nesman JI, Gangestad Primdahl K, Tungen JE, Palmas F, Dalli J, Hansen TV. Synthesis, Structural Confirmation, and Biosynthesis of 22-OH-PD1n-3 DPA. Molecules 2019;24:E3228. [PMID: 31491851 DOI: 10.3390/molecules24183228] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
67 Libby P. Targeting Inflammatory Pathways in Cardiovascular Disease: The Inflammasome, Interleukin-1, Interleukin-6 and Beyond. Cells 2021;10:951. [PMID: 33924019 DOI: 10.3390/cells10040951] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
68 Barnig C, Bezema T, Calder PC, Charloux A, Frossard N, Garssen J, Haworth O, Dilevskaya K, Levi-Schaffer F, Lonsdorfer E, Wauben M, Kraneveld AD, Te Velde AA. Activation of Resolution Pathways to Prevent and Fight Chronic Inflammation: Lessons From Asthma and Inflammatory Bowel Disease. Front Immunol 2019;10:1699. [PMID: 31396220 DOI: 10.3389/fimmu.2019.01699] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
69 Hansen TV, Vik A, Serhan CN. The Protectin Family of Specialized Pro-resolving Mediators: Potent Immunoresolvents Enabling Innovative Approaches to Target Obesity and Diabetes. Front Pharmacol 2018;9:1582. [PMID: 30705632 DOI: 10.3389/fphar.2018.01582] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 12.0] [Reference Citation Analysis]
70 Mahesh S, Shah V, Mallappa M, Vithoulkas G. Psoriasis cases of same diagnosis but different phenotypes-Management through individualized homeopathic therapy. Clin Case Rep 2019;7:1499-507. [PMID: 31428376 DOI: 10.1002/ccr3.2197] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
71 Aubeux D, Peters OA, Hosseinpour S, Tessier S, Geoffroy V, Pérez F, Gaudin A. Specialized pro-resolving lipid mediators in endodontics: a narrative review. BMC Oral Health 2021;21:276. [PMID: 34030680 DOI: 10.1186/s12903-021-01619-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
72 El-Ansary A, Chirumbolo S, Bhat RS, Dadar M, Ibrahim EM, Bjørklund G. The Role of Lipidomics in Autism Spectrum Disorder. Mol Diagn Ther 2020;24:31-48. [PMID: 31691195 DOI: 10.1007/s40291-019-00430-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
73 Hale BJ, Fernandez RF, Kim SQ, Diaz VD, Jackson SN, Liu L, Brenna JT, Hermann BP, Geyer CB, Ellis JM. Acyl-CoA synthetase 6 enriches seminiferous tubules with the ω-3 fatty acid docosahexaenoic acid and is required for male fertility in the mouse. J Biol Chem 2019;294:14394-405. [PMID: 31399511 DOI: 10.1074/jbc.RA119.009972] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
74 Mazidimoradi A, Alemzadeh E, Alemzadeh E, Salehiniya H. The effect of polyunsaturated fatty acids on the severity and mortality of COVID patients: A systematic review. Life Sci 2022;:120489. [PMID: 35358595 DOI: 10.1016/j.lfs.2022.120489] [Reference Citation Analysis]
75 Lasola JJM, Kamdem H, McDaniel MW, Pearson RM. Biomaterial-Driven Immunomodulation: Cell Biology-Based Strategies to Mitigate Severe Inflammation and Sepsis. Front Immunol 2020;11:1726. [PMID: 32849612 DOI: 10.3389/fimmu.2020.01726] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
76 Fattori V, Pinho-Ribeiro FA, Staurengo-Ferrari L, Borghi SM, Rossaneis AC, Casagrande R, Verri WA Jr. The specialised pro-resolving lipid mediator maresin 1 reduces inflammatory pain with a long-lasting analgesic effect. Br J Pharmacol 2019;176:1728-44. [PMID: 30830967 DOI: 10.1111/bph.14647] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 8.3] [Reference Citation Analysis]
77 Tułowiecka N, Kotlęga D, Bohatyrewicz A, Szczuko M. Could Lipoxins Represent a New Standard in Ischemic Stroke Treatment? Int J Mol Sci 2021;22:4207. [PMID: 33921615 DOI: 10.3390/ijms22084207] [Reference Citation Analysis]
78 D'Ângelo MQ, Queiroz-Junior CM, Maltos KLM, Ferreira AJ, Pacheco CMDF, Soares RV. The blockade of kappa opioid receptors exacerbates alveolar bone resorption in rats. Arch Oral Biol 2020;120:104923. [PMID: 33091661 DOI: 10.1016/j.archoralbio.2020.104923] [Reference Citation Analysis]
79 Yellepeddi VK, Baker OJ. Predictive modeling of aspirin-triggered resolvin D1 pharmacokinetics for the study of Sjögren's syndrome. Clin Exp Dent Res 2020;6:225-35. [PMID: 32250566 DOI: 10.1002/cre2.260] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
80 Chistyakov DV, Astakhova AA, Goriainov SV, Sergeeva MG. Comparison of PPAR Ligands as Modulators of Resolution of Inflammation, via Their Influence on Cytokines and Oxylipins Release in Astrocytes. Int J Mol Sci 2020;21:E9577. [PMID: 33339154 DOI: 10.3390/ijms21249577] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
81 Jun B, Mukherjee PK, Asatryan A, Kautzmann MA, Heap J, Gordon WC, Bhattacharjee S, Yang R, Petasis NA, Bazan NG. Elovanoids are novel cell-specific lipid mediators necessary for neuroprotective signaling for photoreceptor cell integrity. Sci Rep 2017;7:5279. [PMID: 28706274 DOI: 10.1038/s41598-017-05433-7] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 6.6] [Reference Citation Analysis]
82 Cai B, Kasikara C, Doran AC, Ramakrishnan R, Birge RB, Tabas I. MerTK signaling in macrophages promotes the synthesis of inflammation resolution mediators by suppressing CaMKII activity. Sci Signal 2018;11:eaar3721. [PMID: 30254055 DOI: 10.1126/scisignal.aar3721] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 9.8] [Reference Citation Analysis]
83 de Gaetano M, Tighe C, Gahan K, Zanetti A, Chen J, Newson J, Cacace A, Marai M, Gaffney A, Brennan E, Kantharidis P, Cooper ME, Leroy X, Perretti M, Gilroy D, Godson C, Guiry PJ. Asymmetric Synthesis and Biological Screening of Quinoxaline-Containing Synthetic Lipoxin A4 Mimetics (QNX-sLXms). J Med Chem 2021;64:9193-216. [PMID: 34138563 DOI: 10.1021/acs.jmedchem.1c00403] [Reference Citation Analysis]
84 Martinez RM, Fattori V, Saito P, Pinto IC, Rodrigues CCA, Melo CPB, Bussmann AJC, Staurengo-Ferrari L, Bezerra JR, Vignoli JA, Baracat MM, Georgetti SR, Verri WA Jr, Casagrande R. The Lipoxin Receptor/FPR2 Agonist BML-111 Protects Mouse Skin Against Ultraviolet B Radiation. Molecules 2020;25:E2953. [PMID: 32604968 DOI: 10.3390/molecules25122953] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
85 Colas RA, Souza PR, Walker ME, Burton M, Zasłona Z, Curtis AM, Marques RM, Dalli J. Impaired Production and Diurnal Regulation of Vascular RvDn-3 DPA Increase Systemic Inflammation and Cardiovascular Disease. Circ Res 2018;122:855-63. [PMID: 29437834 DOI: 10.1161/CIRCRESAHA.117.312472] [Cited by in Crossref: 30] [Cited by in F6Publishing: 19] [Article Influence: 7.5] [Reference Citation Analysis]
86 Dalli J, Serhan CN. Pro-Resolving Mediators in Regulating and Conferring Macrophage Function. Front Immunol 2017;8:1400. [PMID: 29163481 DOI: 10.3389/fimmu.2017.01400] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 10.8] [Reference Citation Analysis]
87 Fuentes NR, Salinas ML, Kim E, Chapkin RS. Emerging role of chemoprotective agents in the dynamic shaping of plasma membrane organization. Biochim Biophys Acta Biomembr 2017;1859:1668-78. [PMID: 28342710 DOI: 10.1016/j.bbamem.2017.03.014] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
88 Hussein H, Kishen A. Local immunomodulatory effects of intracanal medications in apical periodontitis. J Endod 2022:S0099-2399(22)00035-8. [PMID: 35032538 DOI: 10.1016/j.joen.2022.01.003] [Reference Citation Analysis]
89 Nieman DC, Pence BD. Exercise immunology: Future directions. J Sport Health Sci 2020;9:432-45. [PMID: 32928447 DOI: 10.1016/j.jshs.2019.12.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
90 Hwang SM, Chung G, Kim YH, Park CK. The Role of Maresins in Inflammatory Pain: Function of Macrophages in Wound Regeneration. Int J Mol Sci 2019;20:E5849. [PMID: 31766461 DOI: 10.3390/ijms20235849] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
91 Miao J, Zhong J, Lan J, Ye S, Ye P, Li S, You A, Chen X, Liu X, Li H. Paeonol attenuates inflammation by confining HMGB1 to the nucleus. J Cell Mol Med 2021;25:2885-99. [PMID: 33534963 DOI: 10.1111/jcmm.16319] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
92 Pascoal LB, Palma BB, Chaim FHM, de Castro MM, Damázio TA, Franceschini APMF, Milanski M, Velloso LA, Leal RF. New translational and experimental insights into the role of pro-resolving lipid mediators in inflammatory bowel disease. World J Exp Med 2022; 12(1): 1-15 [DOI: 10.5493/wjem.v12.i1.1] [Reference Citation Analysis]
93 Fong TCT. Indirect Effects of Body Mass Index Growth on Glucose Dysregulation via Inflammation: Causal Moderated Mediation Analysis. Obes Facts 2019;12:316-27. [PMID: 31132775 DOI: 10.1159/000500422] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
94 Nolsøe JMJ, Aursnes M, Stenstrøm YH, Hansen TV. Some Biogenetic Considerations Regarding the Marine Natural Product (-)-Mucosin. Molecules 2019;24:E4147. [PMID: 31731797 DOI: 10.3390/molecules24224147] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
95 Sima C, Paster B, Van Dyke TE. Function of Pro-Resolving Lipid Mediator Resolvin E1 in Type 2 Diabetes. Crit Rev Immunol 2018;38:343-65. [PMID: 30806214 DOI: 10.1615/CritRevImmunol.2018026750] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 4.3] [Reference Citation Analysis]
96 Serhan CN. Discovery of specialized pro-resolving mediators marks the dawn of resolution physiology and pharmacology. Mol Aspects Med 2017;58:1-11. [PMID: 28263773 DOI: 10.1016/j.mam.2017.03.001] [Cited by in Crossref: 103] [Cited by in F6Publishing: 93] [Article Influence: 20.6] [Reference Citation Analysis]
97 Lee DH, Kim TM, Kim JK, Park C. ETV2/ER71 Transcription Factor as a Therapeutic Vehicle for Cardiovascular Disease. Theranostics 2019;9:5694-705. [PMID: 31534512 DOI: 10.7150/thno.35300] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
98 Noureddin M, Muthiah MD, Sanyal AJ. Drug discovery and treatment paradigms in nonalcoholic steatohepatitis. Endocrinol Diabetes Metab 2020;3:e00105. [PMID: 33102791 DOI: 10.1002/edm2.105] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
99 Martu MA, Maftei GA, Luchian I, Stefanescu OM, Scutariu MM, Solomon SM. The Effect of Acknowledged and Novel Anti-Rheumatic Therapies on Periodontal Tissues-A Narrative Review. Pharmaceuticals (Basel) 2021;14:1209. [PMID: 34959607 DOI: 10.3390/ph14121209] [Reference Citation Analysis]
100 Das UN. Can Bioactive Lipid Arachidonic Acid Prevent and Ameliorate COVID-19? Medicina (Kaunas) 2020;56:E418. [PMID: 32825011 DOI: 10.3390/medicina56090418] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
101 Mathew D, Torres RM. Lysophosphatidic Acid Is an Inflammatory Lipid Exploited by Cancers for Immune Evasion via Mechanisms Similar and Distinct From CTLA-4 and PD-1. Front Immunol 2020;11:531910. [PMID: 33584637 DOI: 10.3389/fimmu.2020.531910] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
102 Bazan NG. Docosanoids and elovanoids from omega-3 fatty acids are pro-homeostatic modulators of inflammatory responses, cell damage and neuroprotection. Mol Aspects Med 2018;64:18-33. [PMID: 30244005 DOI: 10.1016/j.mam.2018.09.003] [Cited by in Crossref: 62] [Cited by in F6Publishing: 59] [Article Influence: 15.5] [Reference Citation Analysis]
103 Limoli DH, Hoffman LR. Help, hinder, hide and harm: what can we learn from the interactions between Pseudomonas aeruginosa and Staphylococcus aureus during respiratory infections? Thorax 2019;74:684-92. [PMID: 30777898 DOI: 10.1136/thoraxjnl-2018-212616] [Cited by in Crossref: 58] [Cited by in F6Publishing: 47] [Article Influence: 19.3] [Reference Citation Analysis]
104 Hasturk H, Schulte F, Martins M, Sherzai H, Floros C, Cugini M, Chiu CJ, Hardt M, Van Dyke T. Safety and Preliminary Efficacy of a Novel Host-Modulatory Therapy for Reducing Gingival Inflammation. Front Immunol 2021;12:704163. [PMID: 34589083 DOI: 10.3389/fimmu.2021.704163] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
105 Wallet SM, Puri V, Gibson FC. Linkage of Infection to Adverse Systemic Complications: Periodontal Disease, Toll-Like Receptors, and Other Pattern Recognition Systems. Vaccines (Basel) 2018;6:E21. [PMID: 29621153 DOI: 10.3390/vaccines6020021] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
106 Jo WS, Kim SD, Jeong SK, Oh SJ, Park MT, Lee CG, Kang YR, Jeong MH. Resveratrol analogue, HS-1793, inhibits inflammatory mediator release from macrophages by interfering with the TLR4 mediated NF-κB activation. Food Sci Biotechnol. [DOI: 10.1007/s10068-022-01052-9] [Reference Citation Analysis]
107 Land WG. Use of DAMPs and SAMPs as Therapeutic Targets or Therapeutics: A Note of Caution. Mol Diagn Ther 2020;24:251-62. [PMID: 32248387 DOI: 10.1007/s40291-020-00460-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
108 Gallo CG, Fiorino S, Posabella G, Antonacci D, Tropeano A, Pausini E, Pausini C, Guarniero T, Hong W, Giampieri E, Corazza I, Loiacono R, Loggi E, de Biase D, Zippi M, Lari F, Zancanaro M. The function of specialized pro-resolving endogenous lipid mediators, vitamins, and other micronutrients in the control of the inflammatory processes: Possible role in patients with SARS-CoV-2 related infection. Prostaglandins Other Lipid Mediat 2022;:106619. [PMID: 35032665 DOI: 10.1016/j.prostaglandins.2022.106619] [Reference Citation Analysis]
109 Kim EM, Oh PS, Boud F, Jeong HJ, Lim ST, Sohn MH. Rodent Leukocyte Isolation and Radiolabeling for Inflammation Imaging Study. Nucl Med Mol Imaging 2020;54:147-55. [PMID: 32582398 DOI: 10.1007/s13139-020-00645-8] [Reference Citation Analysis]
110 Saban DR, Hodges RR, Mathew R, Reyes NJ, Yu C, Kaye R, Swift W, Botten N, Serhan CN, Dartt DA. Resolvin D1 treatment on goblet cell mucin and immune responses in the chronic allergic eye disease (AED) model. Mucosal Immunol 2019;12:145-53. [PMID: 30279513 DOI: 10.1038/s41385-018-0089-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
111 Asatryan A, Bazan NG. Molecular mechanisms of signaling via the docosanoid neuroprotectin D1 for cellular homeostasis and neuroprotection. J Biol Chem 2017;292:12390-7. [PMID: 28615451 DOI: 10.1074/jbc.R117.783076] [Cited by in Crossref: 40] [Cited by in F6Publishing: 23] [Article Influence: 8.0] [Reference Citation Analysis]
112 Sharma S, Tiarks G, Haight J, Bassuk AG. Neuropathophysiological Mechanisms and Treatment Strategies for Post-traumatic Epilepsy. Front Mol Neurosci 2021;14:612073. [PMID: 33708071 DOI: 10.3389/fnmol.2021.612073] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
113 Pachathundikandi SK, Blaser N, Backert S. Mechanisms of Inflammasome Signaling, microRNA Induction and Resolution of Inflammation by Helicobacter pylori. Curr Top Microbiol Immunol 2019;421:267-302. [PMID: 31123893 DOI: 10.1007/978-3-030-15138-6_11] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
114 Thoo L, Noti M, Krebs P. Keep calm: the intestinal barrier at the interface of peace and war. Cell Death Dis 2019;10:849. [PMID: 31699962 DOI: 10.1038/s41419-019-2086-z] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 9.0] [Reference Citation Analysis]
115 George B, Suchithra TV, Bhatia N. Burn injury induces elevated inflammatory traffic: the role of NF-κB. Inflamm Res 2021;70:51-65. [PMID: 33245371 DOI: 10.1007/s00011-020-01426-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
116 Narimanyan M, Jamalyan K, Balyan A, Barth A, Palm S, Wikman G, Panossian A. Early intervention with Kan Jang® to treat upper-respiratory tract infections: A randomized, quadruple-blind study. J Tradit Complement Med 2021;11:552-62. [PMID: 34765519 DOI: 10.1016/j.jtcme.2021.06.001] [Reference Citation Analysis]
117 de Sá Coutinho D, Pacheco MT, Frozza RL, Bernardi A. Anti-Inflammatory Effects of Resveratrol: Mechanistic Insights. Int J Mol Sci 2018;19:E1812. [PMID: 29925765 DOI: 10.3390/ijms19061812] [Cited by in Crossref: 85] [Cited by in F6Publishing: 77] [Article Influence: 21.3] [Reference Citation Analysis]
118 Mitri C, Xu Z, Bardin P, Corvol H, Touqui L, Tabary O. Novel Anti-Inflammatory Approaches for Cystic Fibrosis Lung Disease: Identification of Molecular Targets and Design of Innovative Therapies. Front Pharmacol 2020;11:1096. [PMID: 32848733 DOI: 10.3389/fphar.2020.01096] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
119 Sakr A, Rezq S, Ibrahim SM, Soliman E, Baraka MM, Romero DG, Kothayer H. Design and synthesis of novel quinazolinones conjugated ibuprofen, indole acetamide, or thioacetohydrazide as selective COX-2 inhibitors: anti-inflammatory, analgesic and anticancer activities. J Enzyme Inhib Med Chem 2021;36:1810-28. [PMID: 34338135 DOI: 10.1080/14756366.2021.1956912] [Reference Citation Analysis]
120 Ding W, Rivera OC, Kelleher SL, Soybel DI. Macrolets: Outsized Extracellular Vesicles Released from Lipopolysaccharide-Stimulated Macrophages that Trap and Kill Escherichia coli. iScience 2020;23:101135. [PMID: 32442747 DOI: 10.1016/j.isci.2020.101135] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
121 Shibata N, Kunisawa J, Kiyono H. Dietary and Microbial Metabolites in the Regulation of Host Immunity. Front Microbiol 2017;8:2171. [PMID: 29163449 DOI: 10.3389/fmicb.2017.02171] [Cited by in Crossref: 61] [Cited by in F6Publishing: 51] [Article Influence: 12.2] [Reference Citation Analysis]
122 Mazi TA, Borkowski K, Fiehn O, Bowlus CL, Sarkar S, Matsukuma K, Ali MR, Kieffer DA, Wan YY, Stanhope KL, Havel PJ, Newman JW, Medici V. Plasma Oxylipin Profile Discriminates Ethnicities in Subjects with Non-Alcoholic Steatohepatitis: An Exploratory Analysis. Metabolites 2022;12:192. [DOI: 10.3390/metabo12020192] [Reference Citation Analysis]
123 Manickam M, Meenakshisundaram S, Pillaiyar T. Activating endogenous resolution pathways by soluble epoxide hydrolase inhibitors for the management of COVID-19. Arch Pharm (Weinheim) 2021;:e2100367. [PMID: 34802171 DOI: 10.1002/ardp.202100367] [Reference Citation Analysis]
124 Kraft JD, Blomgran R, Lundgaard I, Quiding-Järbrink M, Bromberg JS, Börgeson E. Specialized Pro-Resolving Mediators and the Lymphatic System. Int J Mol Sci 2021;22:2750. [PMID: 33803130 DOI: 10.3390/ijms22052750] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
125 Ren Q. Soluble Epoxide Hydrolase Inhibitor: A Novel Potential Therapeutic or Prophylactic Drug for Psychiatric Disorders. Front Pharmacol 2019;10:420. [PMID: 31105566 DOI: 10.3389/fphar.2019.00420] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
126 Tao L, Pang Y, Wang A, Li L, Shen Y, Xu X, Li J. Functional miR-142a-3p Induces Apoptosis and Macrophage Polarization by Targeting tnfaip2 and glut3 in Grass Carp (Ctenopharyngodon idella). Front Immunol 2021;12:633324. [PMID: 34262558 DOI: 10.3389/fimmu.2021.633324] [Reference Citation Analysis]
127 Kraft JD, Blomgran R, Bergström I, Soták M, Clark M, Rani A, Rajan MR, Dalli J, Nyström S, Quiding‐järbrink M, Bromberg J, Skoog P, Börgeson E. Lipoxins modulate neutrophil oxidative burst, integrin expression and lymphatic transmigration differentially in human health and atherosclerosis. The FASEB Journal 2022;36. [DOI: 10.1096/fj.202101219rr] [Reference Citation Analysis]
128 Hiram R, Xiong F, Naud P, Xiao J, Sirois M, Tanguay JF, Tardif JC, Nattel S. The inflammation-resolution promoting molecule resolvin-D1 prevents atrial proarrhythmic remodelling in experimental right heart disease. Cardiovasc Res 2021;117:1776-89. [PMID: 32866246 DOI: 10.1093/cvr/cvaa186] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
129 Paul JA, Whittington RA, Baldwin MR. Critical Illness and the Frailty Syndrome: Mechanisms and Potential Therapeutic Targets. Anesth Analg 2020;130:1545-55. [PMID: 32384344 DOI: 10.1213/ANE.0000000000004792] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
130 Bolotov DD, Novikov AA, Bolevich S, Novikova NA, Yakovchenko AV. Influence of Systemic Inflammatory Response to Appearance of New Foci of Chronic Inflammation. Serbian Journal of Experimental and Clinical Research 2020;21:3-10. [DOI: 10.2478/sjecr-2020-0013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
131 Rodriguez AR, Spur BW. First total syntheses of the pro-resolving lipid mediators 7(S),13(R),20(S)-Resolvin T1 and 7(S),13(R)-Resolvin T4. Tetrahedron Lett 2020;61:151473. [PMID: 32313313 DOI: 10.1016/j.tetlet.2019.151473] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
132 Kalkman HO, Hersberger M, Walitza S, Berger GE. Disentangling the Molecular Mechanisms of the Antidepressant Activity of Omega-3 Polyunsaturated Fatty Acid: A Comprehensive Review of the Literature. Int J Mol Sci 2021;22:4393. [PMID: 33922396 DOI: 10.3390/ijms22094393] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
133 Frigerio F, Pasqualini G, Craparotta I, Marchini S, van Vliet EA, Foerch P, Vandenplas C, Leclercq K, Aronica E, Porcu L, Pistorius K, Colas RA, Hansen TV, Perretti M, Kaminski RM, Dalli J, Vezzani A. n-3 Docosapentaenoic acid-derived protectin D1 promotes resolution of neuroinflammation and arrests epileptogenesis. Brain 2018;141:3130-43. [PMID: 30307467 DOI: 10.1093/brain/awy247] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
134 Ge Y, Huang M, Yao YM. The Effect and Regulatory Mechanism of High Mobility Group Box-1 Protein on Immune Cells in Inflammatory Diseases. Cells 2021;10:1044. [PMID: 33925132 DOI: 10.3390/cells10051044] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
135 Lan J, Li K, Gresham A, Miao J. Tanshinone IIA sodium sulfonate attenuates inflammation by upregulating circ-Sirt1 and inhibiting the entry of NF-κB into the nucleus. Eur J Pharmacol 2022;914:174693. [PMID: 34896110 DOI: 10.1016/j.ejphar.2021.174693] [Reference Citation Analysis]
136 Serhan CN, Levy BD. Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators. J Clin Invest 2018;128:2657-69. [PMID: 29757195 DOI: 10.1172/JCI97943] [Cited by in Crossref: 410] [Cited by in F6Publishing: 250] [Article Influence: 102.5] [Reference Citation Analysis]
137 de Fáveri C, Fermino PMP, Piovezan AP, Volpato LK. The Inflammatory Role of Pro-Resolving Mediators in Endometriosis: An Integrative Review. Int J Mol Sci 2021;22:4370. [PMID: 33922064 DOI: 10.3390/ijms22094370] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
138 Jin Z, Zheng E, Sareli C, Kolattukudy PE, Niu J. Monocyte Chemotactic Protein-Induced Protein 1 (MCPIP-1): A Key Player of Host Defense and Immune Regulation. Front Immunol 2021;12:727861. [PMID: 34659213 DOI: 10.3389/fimmu.2021.727861] [Reference Citation Analysis]
139 Krishnan V, Booker D, Cunningham G, Jadapalli JK, Kain V, Pullen AB, Halade GV. Pretreatment of carprofen impaired initiation of inflammatory- and overlapping resolution response and promoted cardiorenal syndrome in heart failure. Life Sci 2019;218:224-32. [PMID: 30597172 DOI: 10.1016/j.lfs.2018.12.048] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
140 Fenton OS, Olafson KN, Pillai PS, Mitchell MJ, Langer R. Advances in Biomaterials for Drug Delivery. Adv Mater 2018;:e1705328. [PMID: 29736981 DOI: 10.1002/adma.201705328] [Cited by in Crossref: 239] [Cited by in F6Publishing: 188] [Article Influence: 59.8] [Reference Citation Analysis]
141 Sekheri M, Othman A, Filep JG. β2 Integrin Regulation of Neutrophil Functional Plasticity and Fate in the Resolution of Inflammation. Front Immunol 2021;12:660760. [PMID: 33859651 DOI: 10.3389/fimmu.2021.660760] [Reference Citation Analysis]
142 Fernández-Lázaro D, Sánchez-Serrano N, Mielgo-Ayuso J, García-Hernández JL, González-Bernal JJ, Seco-Calvo J. Long COVID a New Derivative in the Chaos of SARS-CoV-2 Infection: The Emergent Pandemic? J Clin Med 2021;10:5799. [PMID: 34945095 DOI: 10.3390/jcm10245799] [Reference Citation Analysis]
143 Liu G, Liu Q, Shen Y, Kong D, Gong Y, Tao B, Chen G, Guo S, Li J, Zuo S, Yu Y, Yin H, Zhang L, Zhou B, Funk CD, Zhang J, Yu Y. Early treatment with Resolvin E1 facilitates myocardial recovery from ischaemia in mice. Br J Pharmacol 2018;175:1205-16. [PMID: 28925017 DOI: 10.1111/bph.14041] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 5.2] [Reference Citation Analysis]
144 Barksdale C, Kipper FC, Tripathy S, Subbian S, Serhan CN, Panigrahy D. COVID-19 and cancer: start the resolution! Cancer Metastasis Rev 2022. [PMID: 35190921 DOI: 10.1007/s10555-021-10017-z] [Reference Citation Analysis]
145 Thatcher TH, Woeller CF, McCarthy CE, Sime PJ. Quenching the fires: Pro-resolving mediators, air pollution, and smoking. Pharmacol Ther 2019;197:212-24. [PMID: 30759375 DOI: 10.1016/j.pharmthera.2019.02.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
146 Gao Y, Zhang H, Luo L, Lin J, Li D, Zheng S, Huang H, Yan S, Yang J, Hao Y, Li H, Gao Smith F, Jin S. Resolvin D1 Improves the Resolution of Inflammation via Activating NF-κB p50/p50-Mediated Cyclooxygenase-2 Expression in Acute Respiratory Distress Syndrome. J Immunol 2017:ji1700315. [PMID: 28794232 DOI: 10.4049/jimmunol.1700315] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
147 Walker ME, Souza PR, Colas RA, Dalli J. 13-Series resolvins mediate the leukocyte-platelet actions of atorvastatin and pravastatin in inflammatory arthritis. FASEB J 2017;31:3636-48. [PMID: 28465323 DOI: 10.1096/fj.201700268] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
148 Miyazawa K, Fukunaga H, Tatewaki Y, Takano Y, Yamamoto S, Mutoh T, Taki Y. Alzheimer's Disease and Specialized Pro-Resolving Lipid Mediators: Do MaR1, RvD1, and NPD1 Show Promise for Prevention and Treatment? Int J Mol Sci 2020;21:E5783. [PMID: 32806612 DOI: 10.3390/ijms21165783] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
149 Libby P, Loscalzo J, Ridker PM, Farkouh ME, Hsue PY, Fuster V, Hasan AA, Amar S. Inflammation, Immunity, and Infection in Atherothrombosis: JACC Review Topic of the Week. J Am Coll Cardiol 2018;72:2071-81. [PMID: 30336831 DOI: 10.1016/j.jacc.2018.08.1043] [Cited by in Crossref: 191] [Cited by in F6Publishing: 182] [Article Influence: 63.7] [Reference Citation Analysis]
150 Hu J, Vacas S, Feng X, Lutrin D, Uchida Y, Lai IK, Maze M. Dexmedetomidine Prevents Cognitive Decline by Enhancing Resolution of High Mobility Group Box 1 Protein-induced Inflammation through a Vagomimetic Action in Mice. Anesthesiology 2018;128:921-31. [PMID: 29252509 DOI: 10.1097/ALN.0000000000002038] [Cited by in Crossref: 27] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
151 Hoxha M, Rovati GE, Cavanillas AB. The leukotriene receptor antagonist montelukast and its possible role in the cardiovascular field. Eur J Clin Pharmacol 2017;73:799-809. [PMID: 28374082 DOI: 10.1007/s00228-017-2242-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
152 Feng C, Ding Y, Tang L, Gui Y, Shen X, He L, Lu X, Leung WK. Adjunctive Er:YAG laser in non-surgical periodontal therapy of patients with inadequately controlled type 2 diabetes mellitus: A split-mouth randomized controlled study. J Periodontal Res 2021. [PMID: 34610151 DOI: 10.1111/jre.12938] [Reference Citation Analysis]
153 Trindade da Silva CA, Clemente-Napimoga JT, Abdalla HB, Basting RT, Napimoga MH. Peroxisome proliferator-activated receptor-gamma (PPARγ) and its immunomodulation function: current understanding and future therapeutic implications. Expert Rev Clin Pharmacol 2022. [PMID: 35481412 DOI: 10.1080/17512433.2022.2071697] [Reference Citation Analysis]
154 Tungen JE, Aursnes M, Ramon S, Colas RA, Serhan CN, Olberg DE, Nuruddin S, Willoch F, Hansen TV. Synthesis of protectin D1 analogs: novel pro-resolution and radiotracer agents. Org Biomol Chem 2018;16:6818-23. [PMID: 30204204 DOI: 10.1039/c8ob01232f] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
155 Novikov AA, Bolevich S, Vorobjov SI, Novikova NA, Bolotov DD, Yakovchenko AV. Pathogenetic Substantiation of Therapeutic and Preventive Measures in Severe Coronavirus Infection. Serbian Journal of Experimental and Clinical Research 2020;21:189-99. [DOI: 10.2478/sjecr-2020-0043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
156 Li J, Zhang Z, Wang L, Jiang L, Qin Z, Zhao Y, Su B. Maresin 1 Attenuates Lipopolysaccharide-Induced Acute Kidney Injury via Inhibiting NOX4/ROS/NF-κB Pathway. Front Pharmacol 2021;12:782660. [PMID: 34955852 DOI: 10.3389/fphar.2021.782660] [Reference Citation Analysis]
157 Goulet O, Lamazière A, Abi Nader E, Talbotec C, Wolf C, Lambe C. Erythrocyte fatty acid membrane composition in children on long-term parenteral nutrition enriched with ω-3 fatty acids. Am J Clin Nutr 2021:nqab263. [PMID: 34582547 DOI: 10.1093/ajcn/nqab263] [Reference Citation Analysis]
158 Reinertsen AF, Primdahl KG, De Matteis R, Dalli J, Hansen TV. Stereoselective Synthesis, Configurational Assignment and Biological Evaluations of the Lipid Mediator RvD2n-3 DPA. Chemistry 2021;:e202103857. [PMID: 34890076 DOI: 10.1002/chem.202103857] [Reference Citation Analysis]
159 Tang S, Wan M, Huang W, Stanton RC, Xu Y. Maresins: Specialized Proresolving Lipid Mediators and Their Potential Role in Inflammatory-Related Diseases. Mediators Inflamm 2018;2018:2380319. [PMID: 29674943 DOI: 10.1155/2018/2380319] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 6.5] [Reference Citation Analysis]
160 Wang Q, Yan SF, Hao Y, Jin SW. Specialized Pro-resolving Mediators Regulate Alveolar Fluid Clearance during Acute Respiratory Distress Syndrome. Chin Med J (Engl) 2018;131:982-9. [PMID: 29664060 DOI: 10.4103/0366-6999.229890] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
161 Spana C, Taylor AW, Yee DG, Makhlina M, Yang W, Dodd J. Probing the Role of Melanocortin Type 1 Receptor Agonists in Diverse Immunological Diseases. Front Pharmacol 2018;9:1535. [PMID: 30692924 DOI: 10.3389/fphar.2018.01535] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
162 Rodriguez AR, Spur BW. First total synthesis of the pro-resolving lipid mediator 7(S),12(R),13(S)-Resolvin T2 and its 13(R)-epimer. Tetrahedron Lett 2020;61:151857. [PMID: 32863450 DOI: 10.1016/j.tetlet.2020.151857] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
163 Liang F, Guan H, Li W, Zhang X, Liu T, Liu Y, Mei J, Jiang C, Zhang F, Luo B, Zhang Z. Erythropoietin Promotes Infection Resolution and Lowers Antibiotic Requirements in E. coli- and S. aureus-Initiated Infections. Front Immunol 2021;12:658715. [PMID: 33927725 DOI: 10.3389/fimmu.2021.658715] [Reference Citation Analysis]
164 Boff D, Crijns H, Teixeira MM, Amaral FA, Proost P. Neutrophils: Beneficial and Harmful Cells in Septic Arthritis. Int J Mol Sci 2018;19:E468. [PMID: 29401737 DOI: 10.3390/ijms19020468] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
165 White TD, Almutairi A, Tusing YG, Lei X, Ramanadham S. The Impact of the Ca2+-Independent Phospholipase A2β (iPLA2β) on Immune Cells. Biomolecules 2021;11:577. [PMID: 33920898 DOI: 10.3390/biom11040577] [Reference Citation Analysis]
166 Joffre C, Rey C, Layé S. N-3 Polyunsaturated Fatty Acids and the Resolution of Neuroinflammation. Front Pharmacol 2019;10:1022. [PMID: 31607902 DOI: 10.3389/fphar.2019.01022] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 12.7] [Reference Citation Analysis]
167 Reis MB, Pereira PAT, Caetano GF, Leite MN, Galvão AF, Paula-Silva FWG, Frade MAC, Faccioli LH. Lipoxin A4 encapsulated in PLGA microparticles accelerates wound healing of skin ulcers. PLoS One 2017;12:e0182381. [PMID: 28753648 DOI: 10.1371/journal.pone.0182381] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
168 Szukiewicz D, Szewczyk G, Pyzlak M, Stangret A, Bachanek M, Trojanowski S, Alkhalayla H, Wejman J. Anti-inflammatory Action of Metformin with Respect to CX3CL1/CX3CR1 Signaling in Human Placental Circulation in Normal-Glucose Versus High-Glucose Environments. Inflammation 2018;41:2246-64. [PMID: 30097812 DOI: 10.1007/s10753-018-0867-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
169 Lariccia V, Magi S, Serfilippi T, Toujani M, Gratteri S, Amoroso S. Challenges and Opportunities from Targeting Inflammatory Responses to SARS-CoV-2 Infection: A Narrative Review. J Clin Med 2020;9:E4021. [PMID: 33322733 DOI: 10.3390/jcm9124021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
170 Fernandez RF, Pereyra AS, Diaz V, Wilson ES, Litwa KA, Martínez-Gardeazabal J, Jackson SN, Brenna JT, Hermann BP, Eells JB, Ellis JM. Acyl-CoA synthetase 6 is required for brain docosahexaenoic acid retention and neuroprotection during aging. JCI Insight 2021;6:144351. [PMID: 34100386 DOI: 10.1172/jci.insight.144351] [Reference Citation Analysis]
171 Schmitt H, Neufert C, Neurath MF, Atreya R. Resolution of Crohn's disease. Semin Immunopathol 2019;41:737-46. [PMID: 31552470 DOI: 10.1007/s00281-019-00756-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
172 Hansen TV, Dalli J, Serhan CN. The novel lipid mediator PD1n-3 DPA: An overview of the structural elucidation, synthesis, biosynthesis and bioactions. Prostaglandins Other Lipid Mediat 2017;133:103-10. [PMID: 28602942 DOI: 10.1016/j.prostaglandins.2017.06.003] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 5.4] [Reference Citation Analysis]
173 Ding R, Meng Y, Ma X. The Central Role of the Inflammatory Response in Understanding the Heterogeneity of Sepsis-3. Biomed Res Int 2018;2018:5086516. [PMID: 29977913 DOI: 10.1155/2018/5086516] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
174 Sánchez-Fernández A, Zandee S, Mastrogiovanni M, Charabati M, Rubbo H, Prat A, López-Vales R. Administration of Maresin-1 ameliorates the physiopathology of experimental autoimmune encephalomyelitis. J Neuroinflammation 2022;19:27. [PMID: 35109863 DOI: 10.1186/s12974-022-02386-1] [Reference Citation Analysis]
175 Rosenthal MD, Patel J, Staton K, Martindale RG, Moore FA, Upchurch GR Jr. Can Specialized Pro-resolving Mediators Deliver Benefit Originally Expected from Fish Oil? Curr Gastroenterol Rep 2018;20:40. [PMID: 30078085 DOI: 10.1007/s11894-018-0647-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
176 Romano M, Patruno S, Pomilio A, Recchiuti A. Proresolving Lipid Mediators and Receptors in Stem Cell Biology: Concise Review. Stem Cells Transl Med 2019;8:992-8. [PMID: 31187940 DOI: 10.1002/sctm.19-0078] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
177 Hayford FEA, Ozturk M, Dolman RC, Blaauw R, Nienaber A, Loots DT, Brombacher F, Smuts CM, Parihar SP, Malan L. Longer-Term Omega-3 LCPUFA More Effective Adjunct Therapy for Tuberculosis Than Ibuprofen in a C3HeB/FeJ Tuberculosis Mouse Model. Front Immunol 2021;12:659943. [PMID: 33995381 DOI: 10.3389/fimmu.2021.659943] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
178 Rakian A, Rakian R, Shay A, Serhan C, Van Dyke T. Periodontal Stem Cells Synthesize Maresin Conjugate in Tissue Regeneration 3. J Dent Res. [DOI: 10.1177/00220345221090879] [Reference Citation Analysis]
179 Sun X, Gao J, Meng X, Lu X, Zhang L, Chen R. Polarized Macrophages in Periodontitis: Characteristics, Function, and Molecular Signaling. Front Immunol 2021;12:763334. [PMID: 34950140 DOI: 10.3389/fimmu.2021.763334] [Reference Citation Analysis]
180 Pullen AB, Jadapalli JK, Rhourri-Frih B, Halade GV. Re-evaluating the causes and consequences of non-resolving inflammation in chronic cardiovascular disease. Heart Fail Rev 2020;25:381-91. [PMID: 31201605 DOI: 10.1007/s10741-019-09817-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
181 Serini S, Ottes Vasconcelos R, Nascimento Gomes R, Calviello G. Protective Effects of ω-3 PUFA in Anthracycline-Induced Cardiotoxicity: A Critical Review. Int J Mol Sci 2017;18:E2689. [PMID: 29231904 DOI: 10.3390/ijms18122689] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
182 Safavynia SA, Goldstein PA. The Role of Neuroinflammation in Postoperative Cognitive Dysfunction: Moving From Hypothesis to Treatment. Front Psychiatry 2018;9:752. [PMID: 30705643 DOI: 10.3389/fpsyt.2018.00752] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 16.3] [Reference Citation Analysis]
183 Dean S, Wang CS, Nam K, Maruyama CL, Trump BG, Baker OJ. Aspirin Triggered Resolvin D1 reduces inflammation and restores saliva secretion in a Sjögren's syndrome mouse model. Rheumatology (Oxford) 2019;58:1285-92. [PMID: 30877775 DOI: 10.1093/rheumatology/kez072] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
184 Yellepeddi VK, Parashar K, Dean SM, Watt KM, Constance JE, Baker OJ. Predicting Resolvin D1 Pharmacokinetics in Humans with Physiologically-Based Pharmacokinetic Modeling. Clin Transl Sci 2021;14:683-91. [PMID: 33202089 DOI: 10.1111/cts.12930] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
185 Hosomi K, Kiyono H, Kunisawa J. Fatty acid metabolism in the host and commensal bacteria for the control of intestinal immune responses and diseases. Gut Microbes 2020;11:276-84. [PMID: 31120334 DOI: 10.1080/19490976.2019.1612662] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
186 Recchiuti A, Isopi E, Romano M, Mattoscio D. Roles of Specialized Pro-Resolving Lipid Mediators in Autophagy and Inflammation. Int J Mol Sci 2020;21:E6637. [PMID: 32927853 DOI: 10.3390/ijms21186637] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
187 Dakin SG, Ly L, Colas RA, Oppermann U, Wheway K, Watkins B, Dalli J, Carr AJ. Increased 15-PGDH expression leads to dysregulated resolution responses in stromal cells from patients with chronic tendinopathy. Sci Rep 2017;7:11009. [PMID: 28887458 DOI: 10.1038/s41598-017-11188-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]